Detalles de la búsqueda
1.
Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma.
Immunity
; 57(5): 1105-1123.e8, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38703775
2.
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line.
J Transl Med
; 22(1): 329, 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38570798
3.
Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs.
J Transl Med
; 21(1): 626, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37715207
4.
Circulating CD137+ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients.
Int J Mol Sci
; 24(8)2023 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37108276
5.
Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma.
Int J Mol Sci
; 23(11)2022 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35682991
6.
Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis.
Int J Mol Sci
; 23(22)2022 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36430974
7.
Immune effects of CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer: Relief from immunosuppression is associated with clinical response.
EBioMedicine
; 79: 104010, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35477069
8.
Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer.
Clin Cancer Res
; 28(5): 1027-1037, 2022 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34980602
9.
Immunogenic Cell Death and Immunomodulatory Effects of Cabozantinib.
Front Oncol
; 11: 755433, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34745989
10.
The Role of Soluble LAG3 and Soluble Immune Checkpoints Profile in Advanced Head and Neck Cancer: A Pilot Study.
J Pers Med
; 11(7)2021 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34357118
11.
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients.
J Pers Med
; 10(4)2020 11 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33158018
Resultados
1 -
11
de 11
1
Próxima >
>>